We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

December 2, 2010

Momenta Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals Industries Ltd. et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. July 19, 2013

    Teva, Amphastar Protected By Safe Harbor In IP Suit: Judge

    A Massachusetts federal judge ruled Friday that Teva Pharmaceuticals Inc. and Amphastar Pharmaceuticals Inc. cannot be held liable for patent infringement for using a patented quality-control method in the production of their generic versions of blood thinner Lovenox, saying the companies are protected by the Hatch-Waxman Act's safe harbor provision.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS